| The IMmunotherapy Pleural 5-ALA PDT (NCT04400539) | University Hospital, Lille | 2022-05-09 |
| Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) (NCT05308966) | Groupe Francais De Pneumo-Cancerologie | 2022-05-03 |
| Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma (NCT05278975) | RS Oncology LLC | 2022-03-31 |
| Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma (NCT05508555) | Ain Shams University | 2022-03-01 |
| Real World Study of MPM in China (NCT05042557) | Chinese Academy of Medical Sciences | 2021-06-01 |
| SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II (NCT04480372) | Swiss Cancer Institute | 2021-03-17 |
| DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma (NCT04334759) | PrECOG, LLC. | 2021-02-18 |
| Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma (NCT04713761) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-02-01 |
| Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy (NCT04775446) | Centre Hospitalier Intercommunal Creteil | 2020-11-26 |
| Pembrolizumab + Defactinib In Pleural Mesothelioma (NCT04201145) | Raphael Bueno, MD | 2020-09-01 |
| Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma (NCT04525859) | Oncovir, Inc. | 2020-08-19 |
| A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma (NCT04162015) | Memorial Sloan Kettering Cancer Center | 2019-11-12 |
| MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma (NCT04013334) | Momotaro-Gene Inc. | 2019-08-15 |
| Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma (NCT02761863) | Ain Shams University | 2019-07-30 |
| Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma (NCT03710876) | Ferring Ventures Limited | 2019-01-21 |
| Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma (NCT02863055) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-02-04 |
| Autologous Dendritic Cell Vaccination in Mesothelioma (NCT02649829) | University Hospital, Antwerp | 2017-10-03 |
| Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma (NCT03269227) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2017-08-14 |
| MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma. (NCT03412357) | Papworth Hospital NHS Foundation Trust | 2017-08-10 |
| Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma (NCT03177668) | Kissei Pharmaceutical Co., Ltd. | 2017-08-08 |
| Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) (NCT03175172) | Aduro Biotech, Inc. | 2017-05-31 |
| Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM (NCT02436733) | European Organisation for Research and Treatment of Cancer - EORTC | 2016-09-20 |
| Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma (NCT03048474) | The Netherlands Cancer Institute | 2016-09-01 |
| uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung (NCT02755675) | Rigshospitalet, Denmark | 2016-04-01 |
| Alvopem® (Pemetrexed) Safety Assessment (NCT04843007) | NanoAlvand | 2016-03-15 |
| Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma (NCT02611037) | H. Lee Moffitt Cancer Center and Research Institute | 2016-03-04 |
| Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma (NCT02639767) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Nivolumab in Patients With Recurrent Malignant Mesothelioma (NCT02497508) | The Netherlands Cancer Institute | 2015-07-01 |
| Four Versus Six Cycles of Pemetrexed/Platinum for MPM (NCT02497053) | Ain Shams University | 2015-06-01 |
| Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma (NCT01722149) | University of Zurich | 2015-02-19 |
| A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma (NCT02347917) | Sumitomo Pharma Co., Ltd. | 2015-02-01 |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) (NCT02397928) | NovoCure Ltd. | 2015-02-01 |
| Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma (NCT01675765) | Aduro Biotech, Inc. | 2014-09-03 |
| MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC (NCT02369198) | Asbestos Diseases Research Foundation | 2014-09-01 |
| Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma (NCT02269878) | Ain Shams University | 2014-04-01 |
| Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants (NCT02004028) | Verastem, Inc. | 2013-12-12 |
| Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma (NCT01870609) | Verastem, Inc. | 2013-09-01 |
| ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (NCT02194231) | Mario Negri Institute for Pharmacological Research | 2013-07-01 |
| Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin (NCT02049060) | Armando Santoro, MD | 2013-01-01 |
| Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients (NCT01865045) | Armando Santoro, MD | 2012-11-01 |
| Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. (NCT01721018) | Virttu Biologics Limited | 2012-10-01 |
| A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma (NCT01486368) | NCIC Clinical Trials Group | 2012-06-26 |
| Autologous Redirected RNA Meso-CIR T Cells (NCT01355965) | University of Pennsylvania | 2011-05-01 |
| A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma (NCT01279967) | Barts & The London NHS Trust | 2011-01-01 |
| Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy (NCT01265433) | Sellas Life Sciences Group | 2010-12-21 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas (NCT01143545) | National Cancer Institute (NCI) | 2010-12-07 |
| NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed (NCT01098266) | AGC Biologics S.p.A. | 2010-04-12 |
| Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity (NCT01024946) | Memorial Sloan Kettering Cancer Center | 2009-12-01 |
| Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma (NCT01241682) | Erasmus Medical Center | 2009-10-01 |
| Response Evaluation in Malignant Pleural Mesothelioma (NCT00969098) | Istituto Clinico Humanitas | 2009-06-01 |
| Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma (NCT01211275) | The Netherlands Cancer Institute | 2009-05-22 |
| Intrapleural Gene Transfer for Pleural Mesothelioma (NCT01212367) | Abramson Cancer Center at Penn Medicine | 2009-02-01 |
| Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients (NCT00867711) | Istituto Clinico Humanitas | 2009-01-01 |
| An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma (NCT00738582) | Morphotek | 2008-12-31 |
| Short Neoadjuvant Hemithoracic IMRT for MPM (NCT00797719) | University Health Network, Toronto | 2008-10-01 |
| Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) (NCT00700336) | CanBas Co. Ltd. | 2008-05-01 |
| Dasatinib in Resectable Malignant Pleural Mesothelioma (NCT00652574) | M.D. Anderson Cancer Center | 2008-03-12 |
| Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma (NCT00571298) | Brigham and Women's Hospital | 2007-11-01 |
| Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma (NCT00484276) | AGC Biologics S.p.A. | 2007-05-01 |
| Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma (NCT00386815) | Eli Lilly and Company | 2006-10-01 |
| Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma (NCT00886028) | National Institute of Cancerología | 2006-09-01 |
| Dendritic Cell-based Immunotherapy in Mesothelioma (NCT00280982) | Erasmus Medical Center | 2006-01-01 |
| Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma (NCT00272558) | Rigshospitalet, Denmark | 2004-09-01 |
| Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate (NCT00165503) | Dana-Farber Cancer Institute | 2004-04-01 |
| Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate (NCT00165516) | Dana-Farber Cancer Institute | 2004-01-01 |
| Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment (NCT01243632) | Institute of Oncology Ljubljana | 2002-12-01 |
| Trimodality Therapy for Malignant Pleural Mesothelioma (NCT01343264) | HSK Wiesbaden | 2002-11-01 |
| A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma (NCT01353482) | University College, London | |